glucagon-like peptide-1 receptor agonists

Show results for

Unknown (1442)
Transcriptomics (36)
Genomics (21)
Proteomics (10)
Other (2)
Metabolomics (1)

Organisms

Mus musculus (27)
Rattus norvegicus (7)
Homo sapiens (7)
Caenorhabditis elegans (2)
Sus scrofa (1)
Danio rerio (1)

Organisms

Mus musculus (14)
Homo sapiens (2)
Danio rerio (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (21)
ENA (21)
geo (17)
pride (5)
MassIVE (3)
iProX (2)
MetaboLights (1)

Tissue

Brain (1)
Heart (1)
Kidney (1)
Pancreatic islet (1)
Type B pancreatic cell (1)

Disease

Normal (1)
Disease free (1)

Technology Type

Mass Spectrometry (5)
Shotgun proteomics (3)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-independent acquisition (1)

Instrument Platform

Illumina NovaSeq 6000 (3)
Illumina HiSeq 2500 (1)
LTQ Orbitrap Velos (1)
Orbitrap Exactive Pluse (1)
Orbitrap Fusion ETD (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
TripleTOF 5600+ (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2025 (10)
2026 (7)
2015 (6)
2023 (4)
2011 (3)
2024 (3)
2016 (2)
2014 (2)
2022 (2)
2017 (1)
2013 (1)
2012 (1)
2008 (1)
2007 (1)
2005 (1)
2020 (1)
2021 (1)

Metabolite Name

(+)-1,2-Epoxyneomenthyl acetate (1)
(-)-Chimonanthine (1)
(10Z)-Pentadec-10-enoylcarnitine (1)
(13R,14R)-7-Labdene-13,14,15-triol (1)
(22E, 24x)-Ergosta-4,6,8,22-tetraen-3-one (1)
(2E)-Piperamide-C5:1 (1)
(2E,5Z,7E)-Decatrienoylcarnitine (1)
(2E,6Z)-2,6-Nonadien-1-Yl acetate (1)
(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid (1)
(2R)-2-{[(9Z)-Hexadec-9-enoyl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate (1)
(2Z)-6-Hydroxynon-2-enoylcarnitine (1)
(3E,5E,8Z)-Deca-3,5,8-trienedioylcarnitine (1)
(3E,5Z)-1,3,5-Heptatriene (1)
(3Z,6Z)-3,6-Nonadien-1-ol (1)
(3xi,5Z)-1,5-Octadien-3-ol (1)
(4-Hydroxybenzoyl)choline (1)
(4S,8R)-8,9-Dihydroxy-p-menth-1(6)-en-2-one (1)
(R)-1,2-dimethyl-5,6-dihydroxy-tetrahydroisoquinoline (1)
(S)-2-Propylpiperidine (1)
(S)-5'-Deoxy-5'-(methylsulfinyl)adenosine (1)
(S1)-Methoxy-3-heptanethiol (1)
(Z)-1,3-Octadiene (1)
(¡À)-2-Methylbutanal (1)
1,1,1-Trichloroheptane (1)
1,2-Dilauroyl-sn-glycero-3-phosphocholine (1)
1,3-Butadiene (1)
1,3-Dihydro-(2H)-indol-2-one (1)
1-(2-Furanyl)-1-octanone (1)
1-Acetylproline (1)
1-Methoxy-4-(2-propenyl)benzene (1)

First Public Date

2025 (10)
2026 (5)
2023 (3)
2024 (2)
2022 (1)

Study type

Transcription profiling by array (11)
RNA-seq of coding RNA (6)
Other (2)
RNA-seq of coding RNA from single cells (1)
RNA-seq of total RNA (1)

Release Date

2025 (332)
2024 (201)
2022 (172)
2023 (164)
2021 (146)
2020 (90)
2026 (66)
2019 (64)
2018 (64)
2015 (35)
2016 (32)
2017 (28)
2014 (24)
2013 (13)
2011 (9)
2012 (8)
2008 (3)
2007 (3)
2010 (3)
2009 (3)
2005 (1)
2002 (1)
1997 (1)

Lab affiliation

Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany University of Tübingen, Tübingen, Germany (1)
Director, Advanced Clinical Biosystems Research Institute (1)
Institute for Diabetes and Obesity, Helmholtz Zentrum München, 85764 Neuherberg, Germany German Center for Diabetes Research, Neuherberg, Germany (1)
MRC-Laboratory of Medical Sciences (1)
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen (1)

Previous page
1 / 152
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 152
Next page

Sort by:

Relevance

Page size

Single-nucleus RNA-seq of FACS-enriched Glp1r-Sun1-sfGFP nuclei from mouse hypothalamus, dorsal vagal complex, and nodose ganglion

Glucagon-like peptide-1 receptor (GLP1R) agonists such as semaglutide reduce food intake and body weight, and Glp1r-expressing neurons in the hypothalamus and hindbrain mediate these effects. To profile these cells directly, Glp1r-Cre mice were crossed to the Gt(ROSA)26Sor-CAG-Sun1-sfGFP reporter, w...

ORGANISM(S): Mus musculus

2026-09-14 | E-MTAB-17566 | biostudies-arrayexpress

Chronic treatment with glucagon-like peptide-1/glucagon receptor co-agonist causes weight-loss independent improvements in hepatic steatosis

PRJNA1019376 | ENA

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.

Not available

S-EPMC12001313 | biostudies-literature

Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.

Not available

S-EPMC7366314 | biostudies-literature

Small-molecule agonists for the glucagon-like peptide 1 receptor.

Not available